Finance

Lists
600085:SHA
Beijing Tong Ren Tang Co Ltd
CN¥ 24.43
+0.62%
(+0.15) 1D
10-р сарын 12, 15:00:00 (GMT+8)  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 600085...
Open
CN¥ 24.32
High
CN¥ 24.50
Low
CN¥ 24.27
Mkt. cap
33.30 тэрбум
Avg. vol.
4.73 сая
Volume
6.23 сая
Dividend
2.05%
Quarterly dividend
CN¥ 0.13
Ex-dividend date
2026 оны 7-р сарын 1
P/E ratio
34.54
52-wk high
CN¥ 35.87
52-wk low
CN¥ 21.87
EPS
CN¥ 0.71
Shares outstanding
1.37 тэрбум
No. of employees
17 мян
Open
CN¥ 24.32
High
CN¥ 24.50
Low
CN¥ 24.27
Mkt. cap
33.30 тэрбум
Avg. vol.
4.73 сая
Volume
6.23 сая
Dividend
2.05%
Quarterly dividend
CN¥ 0.13
Ex-dividend date
2026 оны 7-р сарын 1
P/E ratio
34.54
52-wk high
CN¥ 35.87
52-wk low
CN¥ 21.87
EPS
CN¥ 0.71
Shares outstanding
1.37 тэрбум
No. of employees
17 мян
News stories
From web sources and news partners
Profile
Tong Ren Tang is a Chinese pharmaceutical company founded in 1669. It is now the largest producer of traditional Chinese medicine. The company headquarters are in Beijing, where they engage in both manufacturing and retail sales. It operates drug stores, predominantly in Chinese-speaking regions. Tong Ren Tang is considered one of the "Big 4" traditional Chinese medicine brands still in existence. The four companies include: Guangyuyuan, Guangzhou Chen Liji, Beijing Tong Ren Tang, and Hangzhou Hu Qing Yu Tang. Tong Ren Tang, and GuangYuYuan have been officially recognized as "China Time-Honored Brands" by the Ministry of Commerce of the People's Republic of China. Wikipedia
About Beijing Tong Ren Tang Co Ltd
CEO-
Employees17.3 мян
Founded1669
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
2025 оны 9-р сар
2025 оны 12-р сар
2026 оны 3-р сар
2026 оны 6-р сар
Revenue
3.54 тэрбум
3.95 тэрбум
4.66 тэрбум
3.72 тэрбум
Cost of goods sold
1.97 тэрбум
2.50 тэрбум
2.72 тэрбум
2.17 тэрбум
Cost of revenue
1.97 тэрбум
2.50 тэрбум
2.72 тэрбум
2.17 тэрбум
Research and development expenses
53.41 сая
144.52 сая
51.64 сая
74.50 сая
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.10 тэрбум
1.30 тэрбум
1.13 тэрбум
1.04 тэрбум
Operating expense
1.16 тэрбум
1.52 тэрбум
1.23 тэрбум
1.16 тэрбум
Total operating expenses
3.13 тэрбум
4.02 тэрбум
3.95 тэрбум
3.33 тэрбум
Operating income
408.67 сая
-73.33 сая
709.73 сая
383.76 сая
Other non operating income
-3.64 сая
-4.50 сая
-3.96 сая
-4.53 сая
EBT including unusual items
346.57 сая
67.54 сая
748.37 сая
431.21 сая
EBT excluding unusual items
418.62 сая
-56.72 сая
750.60 сая
414.06 сая
Income tax expense
88.79 сая
27.32 сая
131.64 сая
112.60 сая
Effective tax rate
25.62%
40.44%
17.59%
26.11%
Other operating expenses
-1.80 сая
58.15 сая
29.98 сая
47.32 сая
Net income
232.06 сая
11.82 сая
471.18 сая
255.01 сая
Net profit margin
6.56%
0.30%
10.10%
6.86%
Earnings per share
-
-
-
-
Interest and investment income
45.55 сая
48.93 сая
70.91 сая
59.45 сая
Interest expense
-30.03 сая
-28.19 сая
-26.08 сая
-24.57 сая
Net interest expenses
15.52 сая
20.74 сая
44.83 сая
34.88 сая
Depreciation and amortization charges
-
-
-
-
EBITDA
495.57 сая
18.15 сая
801.21 сая
477.52 сая
Gain or loss from assets sale
1.87 сая
-25.11 сая
-
-10.41 сая
AI content may include mistakes. Learn more
Google аппс